Literature DB >> 19005491

Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.

Kentaro Kajiya1, Mika Sawane, Reto Huggenberger, Michael Detmar.   

Abstract

We have previously demonstrated that UVB irradiation resulted in impaired function of cutaneous lymphatic vessels, suggesting a crucial role of lymphatic function in the mediation of UVB-induced inflammation. Nonetheless, the molecular mechanisms of lymphatic involvement in inflammation have remained unclear. Here, we show that vascular endothelial growth factor (VEGF)-C expression is downregulated after UVB irradiation, associated with enlargement of lymphatic vessels and with an increase of macrophage infiltration in the dermis. To determine whether activation of VEGF-C/VEGFR-3 signaling might reduce UVB-induced inflammation, mice were exposed to a single dose of UVB irradiation together with intradermal injection of mutant VEGF-C (Cys156Ser), which specifically binds to VEGFR-3 on lymphatic endothelium. We found that the activation of VEGFR-3 attenuated UVB-induced edema formation, associated with a decreased number of CD11b-positive macrophages. Moreover, mutant VEGF-C injection inhibited UVB-induced enlargement of lymphatic vessels and also induced the proliferation of lymphatic endothelial cells. In contrast, treatment with mutant VEGF-C had no effect on blood vessel size or number. These results demonstrate that UVB-induced lymphatic impairment is mediated by downregulation of VEGF-C expression and that the activation of the VEGF-C/VEGFR-3 pathway might represent a feasible target for the prevention of UVB-induced inflammation by promoting lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005491     DOI: 10.1038/jid.2008.351

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  35 in total

1.  Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation.

Authors:  Simon Schwager; Silvana Renner; Teresa Hemmerle; Sinem Karaman; Steven T Proulx; Roman Fetz; Alexandra Michaela Golding-Ochsenbein; Philipp Probst; Cornelia Halin; Dario Neri; Michael Detmar
Journal:  JCI Insight       Date:  2018-12-06

2.  Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.

Authors:  S Ling; Q Li; H Lin; W Li; T Wang; H Ye; J Yang; X Jia; Y Sun
Journal:  Eye (Lond)       Date:  2012-09-14       Impact factor: 3.775

3.  Apelin attenuates UVB-induced edema and inflammation by promoting vessel function.

Authors:  Mika Sawane; Hiroyasu Kidoya; Fumitaka Muramatsu; Nobuyuki Takakura; Kentaro Kajiya
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

Review 4.  Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?

Authors:  Gabriella R Abouelkheir; Bradley D Upchurch; Joseph M Rutkowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-07

Review 5.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

6.  Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection.

Authors:  Christopher P Loo; Nicholas A Nelson; Ryan S Lane; Jamie L Booth; Sofia C Loprinzi Hardin; Archana Thomas; Mark K Slifka; Jeffrey C Nolz; Amanda W Lund
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

7.  An important role of lymphatic vessel activation in limiting acute inflammation.

Authors:  Reto Huggenberger; Shoib S Siddiqui; Daniela Brander; Stefan Ullmann; Kathrin Zimmermann; Maria Antsiferova; Sabine Werner; Kari Alitalo; Michael Detmar
Journal:  Blood       Date:  2011-03-01       Impact factor: 22.113

8.  Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.

Authors:  G Jurisic; J P Sundberg; A Bleich; E H Leiter; K W Broman; G Buechler; L Alley; D Vestweber; M Detmar
Journal:  Genes Immun       Date:  2010-03-11       Impact factor: 2.676

9.  Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice.

Authors:  Quan Zhou; Ruolin Guo; Ronald Wood; Brendan F Boyce; Qianqian Liang; Yong-Jun Wang; Edward M Schwarz; Lianping Xing
Journal:  Arthritis Rheum       Date:  2011-08

10.  VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Real; Stephen B Fleming; Andrew A Mercer
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.